Click to Share
 

National Tay-Sachs Press Releases

Exclusive News
Topics Locations Industries Dates

By NTSAD
First human trial for Tay-Sachs, Canavan and other rare enzyme deficiency diseases plans to begin in early 2013 thanks to NTSAD, the nation's oldest patient advocacy organization, which leads efforts to find a cure or treatment.

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share